We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Saliva Test To Detect Pre-Eclampsia

By HospiMedica staff writers
Posted on 14 May 2007
A simple saliva test has been developed to detect early-stage pre-eclampsia in pregnant women.

The new test works by monitoring levels of urate, a salt of uric acid, increased levels of which are thought to be due to impaired kidney excretion in pre-eclampsia. More...
It is simple, cheap, non-invasive, and accurate. Designed to be used at home, the test is expected to be more reliable than traditional blood pressure and urine tests, which are currently conducted in physicians' offices and hospitals. High blood pressure can be caused by a variety of factors other than pre-eclampsia, and even when a woman develops pre-eclampsia, problems with high blood pressure may not occur until the latter stages.

Cath Driscoll reported in the journal Chemistry and Industry that the test is being trialed at St. Richards Hospital (Chichester, UK). Pre-eclampisa is a potentially fatal condition that kills thousands of babies every year. It is also one of leading the causes of maternal mortality. Thought to be the result of problems relating to the implantation of the placenta, the main diagnostic symptoms are raised blood pressure and the excretion of protein in the urine. While there is no cure, other than the delivery of the baby and removal of the faulty placenta, early detection and management of the problem can have a big impact on patient outcome.

The trial will eventually involve 1,000 women. Trial subjects will send away saliva-wiped swabs for analysis. Results are expected early next year. The ultimate aim is to develop a traffic light detection kit for use in the home.


Related Links:
St. Richards Hospital

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.